Meng Gu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Meng Gu has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
Daniel M. Spielman
Department of Radiology, Stanford University, Stanford, California, USA
5 shared publicationsAdolf Pfefferbaum
Neuroscience Program SRI International Menlo Park CA USA
2 shared publications- Daniel M. Spielman
Department of Radiology Stanford University School of Medicine Stanford California USA
2 shared publications Dirk Mayer
Department of Radiology Stanford University Stanford CA USA
2 shared publicationsEdith V. Sullivan
Neuroscience Program SRI International Menlo Park CA USA
2 shared publications- Allan L. Reiss
Center for Interdisciplinary Brain Sciences Research, Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, USA
1 shared publication
Latest Publications
- Open Access
- 8 October 2026
- Published by Springer Nature in Journal of Autism and Developmental Disorders
- p. 1-16
Cerebellar Crus I and Crus II Structure and Excitation/Inhibition Balance in Autism Spectrum Disorder
- 8 October 2026
- Published by Springer Nature in Journal of Autism and Developmental Disorders
- p. 1-16
Open AccessCerebellar Crus I and Crus II Structure and Excitation/Inhibition Balance in Autism Spectrum Disorder
- 1 May 2017
- Published by Elsevier in Biological Psychiatry
- Vol. 81 (10) , S127-S128
310. Simultaneous [18F]Flumazenil-Positron Emission Tomography and GABA-Magnetic Resonance Spectroscopy in Adults with Autism and Healthy Volunteers
- 1 May 2017
- Published by Elsevier in Biological Psychiatry
- Vol. 81 (10) , S127-S128
310. Simultaneous [18F]Flumazenil-Positron Emission Tomography and GABA-Magnetic Resonance Spectroscopy in Adults with Autism and Healthy Volunteers
- 31 March 2017
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 79 (1) , 41-47
GABA editing with macromolecule suppression using an improved MEGA‐SPECIAL sequence
Purpose: The most common γ‐aminobutyric‐acid (GABA) editing approach, MEGA‐PRESS, uses J‐editing to measure GABA distinct from larger overlapping metabolites, but suffers contamination from coedited macromolecules (MMs) comprising 40 to 60% of the observed signal. MEGA‐SPECIAL is an alternative method with better MM suppression, but is not widely used primarily because of its relatively poor spatial localization. Our goal was to develop an improved MM‐suppressed GABA editing sequence at 3 Tesla.Methods: We modified a single‐voxel MEGA‐SPECIAL sequence with an oscillating readout gradient for improved spatial localization, and used very selective 30‐ms editing pulses for improved suppression of coedited MMs.Results: Simulation and in vivo experiments confirmed excellent MM suppression, insensitive to the range of B0 frequency drifts typically encountered in vivo. Both intersubject and intrasubject studies showed that MMs, when suppressed by the improved MEGA‐SPECIAL method, contributed approximately 40% to the corresponding MEGA‐PRESS measurements. From the intersubject study, the coefficient of variation for GABA+/Cre (MEGA‐PRESS) was 11.2% versus 7% for GABA/Cre (improved MEGA‐SPECIAL), demonstrating significantly reduced variance (P = 0.005), likely coming from coedited MMs.Conclusions: This improved MEGA‐SPECIAL sequence provides unbiased GABA measurements with reduced variance as compared with conventional MEGA‐PRESS. This approach is also relatively insensitive to the range of B0 drifts typically observed in in vivo human studies. Magn Reson Med 79:41–47, 2018. © 2017 International Society for Magnetic Resonance in Medicine.
- 31 March 2017
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 79 (1) , 41-47
GABA editing with macromolecule suppression using an improved MEGA‐SPECIAL sequence
Purpose: The most common γ‐aminobutyric‐acid (GABA) editing approach, MEGA‐PRESS, uses J‐editing to measure GABA distinct from larger overlapping metabolites, but suffers contamination from coedited macromolecules (MMs) comprising 40 to 60% of the observed signal. MEGA‐SPECIAL is an alternative method with better MM suppression, but is not widely used primarily because of its relatively poor spatial localization. Our goal was to develop an improved MM‐suppressed GABA editing sequence at 3 Tesla.Methods: We modified a single‐voxel MEGA‐SPECIAL sequence with an oscillating readout gradient for improved spatial localization, and used very selective 30‐ms editing pulses for improved suppression of coedited MMs.Results: Simulation and in vivo experiments confirmed excellent MM suppression, insensitive to the range of B0 frequency drifts typically encountered in vivo. Both intersubject and intrasubject studies showed that MMs, when suppressed by the improved MEGA‐SPECIAL method, contributed approximately 40% to the corresponding MEGA‐PRESS measurements. From the intersubject study, the coefficient of variation for GABA+/Cre (MEGA‐PRESS) was 11.2% versus 7% for GABA/Cre (improved MEGA‐SPECIAL), demonstrating significantly reduced variance (P = 0.005), likely coming from coedited MMs.Conclusions: This improved MEGA‐SPECIAL sequence provides unbiased GABA measurements with reduced variance as compared with conventional MEGA‐PRESS. This approach is also relatively insensitive to the range of B0 drifts typically observed in in vivo human studies. Magn Reson Med 79:41–47, 2018. © 2017 International Society for Magnetic Resonance in Medicine.
- Open Access
- 28 August 2013
- Published by Springer Nature in Journal of Neurodevelopmental Disorders
- Vol. 5 (1) , 20
Aberrant basal ganglia metabolism in fragile X syndrome: a magnetic resonance spectroscopy study
Background: The profile of cognitive and behavioral variation observed in individuals with fragile X syndrome (FXS), the most common known cause of inherited intellectual impairment, suggests aberrant functioning of specific brain systems. Research investigating animal models of FXS, characterized by limited or lack of fragile X mental retardation protein, (FMRP), has linked brain dysfunction to deficits in the cholinergic and glutamatergic systems. Thus, we sought to examine in vivo levels of neurometabolites related to cholinergic and glutamatergic functioning in males and females with FXS. Methods: The study participants included 18 adolescents and young adults with FXS, and a comparison group of 18 individuals without FXS matched for age, sex and general intellectual functioning. Proton magnetic resonance spectroscopy (MRS) was used to assess neurometabolite levels in the caudate nucleus, a region known to be greatly enlarged and involved in abnormal brain circuitry in individuals with FXS. A general linear model framework was used to compare group differences in metabolite concentration. Results: We observed a decrease in choline (P = 0.027) and in glutamate + glutamine (P = 0.032) in the caudate nucleus of individuals with FXS, relative to individuals in the comparison group. Conclusions: This study provides evidence of metabolite differences in the caudate nucleus, a brain region of potential importance to our understanding of the neural deficits underlying FXS. These metabolic differences may be related to aberrant receptor signaling seen in animal models. Furthermore, identification of the specific neurometabolites involved in FXS dysfunction could provide critical biomarkers for the design and efficacy tracking of disease-specific pharmacological treatments.
- 28 August 2013
- Published by Springer Nature in Journal of Neurodevelopmental Disorders
- Vol. 5 (1) , 20
Open AccessAberrant basal ganglia metabolism in fragile X syndrome: a magnetic resonance spectroscopy study
Background: The profile of cognitive and behavioral variation observed in individuals with fragile X syndrome (FXS), the most common known cause of inherited intellectual impairment, suggests aberrant functioning of specific brain systems. Research investigating animal models of FXS, characterized by limited or lack of fragile X mental retardation protein, (FMRP), has linked brain dysfunction to deficits in the cholinergic and glutamatergic systems. Thus, we sought to examine in vivo levels of neurometabolites related to cholinergic and glutamatergic functioning in males and females with FXS. Methods: The study participants included 18 adolescents and young adults with FXS, and a comparison group of 18 individuals without FXS matched for age, sex and general intellectual functioning. Proton magnetic resonance spectroscopy (MRS) was used to assess neurometabolite levels in the caudate nucleus, a region known to be greatly enlarged and involved in abnormal brain circuitry in individuals with FXS. A general linear model framework was used to compare group differences in metabolite concentration. Results: We observed a decrease in choline (P = 0.027) and in glutamate + glutamine (P = 0.032) in the caudate nucleus of individuals with FXS, relative to individuals in the comparison group. Conclusions: This study provides evidence of metabolite differences in the caudate nucleus, a brain region of potential importance to our understanding of the neural deficits underlying FXS. These metabolic differences may be related to aberrant receptor signaling seen in animal models. Furthermore, identification of the specific neurometabolites involved in FXS dysfunction could provide critical biomarkers for the design and efficacy tracking of disease-specific pharmacological treatments.
- 4 July 2012
- Published by Wiley in NMR in Biomedicine
- Vol. 26 (2) , 164-172
Quantification of glutamate and glutamine using constant‐time point‐resolved spectroscopy at 3 T
Separate quantification of glutamate (Glu) and glutamine (Gln) using conventional MRS on clinical scanners is challenging. In previous work, constant‐time point‐resolved spectroscopy (CT‐PRESS) was optimized at 3 T to detect Glu, but did not resolve Gln. To quantify Glu and Gln, a time‐domain basis set was constructed taking into account metabolite T2 relaxation times and dephasing from B0 inhomogeneity. Metabolite concentrations were estimated by fitting the basis one‐dimensional CT‐PRESS diagonal magnitude spectra to the measured spectrum. This method was first validated using seven custom‐built phantoms containing variable metabolite concentrations, and then applied to in vivo data acquired in rats exposed to vaporized ethanol and controls. Separate metabolite quantification revealed increased Gln after 16 weeks and increased Glu after 24 weeks of vaporized ethanol exposure in ethanol‐treated compared with control rats. Without separate quantification, the signal from the combined resonances of Glu and Gln (Glx) showed an increase at both 16 and 24 weeks in ethanol‐exposed rats, precluding the determination of the independent and differential contribution of each metabolite at each time. Copyright © 2012 John Wiley & Sons, Ltd.
- 4 July 2012
- Published by Wiley in NMR in Biomedicine
- Vol. 26 (2) , 164-172
Quantification of glutamate and glutamine using constant‐time point‐resolved spectroscopy at 3 T
Separate quantification of glutamate (Glu) and glutamine (Gln) using conventional MRS on clinical scanners is challenging. In previous work, constant‐time point‐resolved spectroscopy (CT‐PRESS) was optimized at 3 T to detect Glu, but did not resolve Gln. To quantify Glu and Gln, a time‐domain basis set was constructed taking into account metabolite T2 relaxation times and dephasing from B0 inhomogeneity. Metabolite concentrations were estimated by fitting the basis one‐dimensional CT‐PRESS diagonal magnitude spectra to the measured spectrum. This method was first validated using seven custom‐built phantoms containing variable metabolite concentrations, and then applied to in vivo data acquired in rats exposed to vaporized ethanol and controls. Separate metabolite quantification revealed increased Gln after 16 weeks and increased Glu after 24 weeks of vaporized ethanol exposure in ethanol‐treated compared with control rats. Without separate quantification, the signal from the combined resonances of Glu and Gln (Glx) showed an increase at both 16 and 24 weeks in ethanol‐exposed rats, precluding the determination of the independent and differential contribution of each metabolite at each time. Copyright © 2012 John Wiley & Sons, Ltd.
- Open Access
- 22 January 2009
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 61 (2) , 267-272
Parallel spectroscopic imaging reconstruction with arbitrary trajectories using k‐space sparse matrices
Parallel imaging reconstruction has been successfully applied to magnetic resonance spectroscopic imaging (MRSI) to reduce scan times. For undersampled k‐space data on a Cartesian grid, the reconstruction can be achieved in image domain using a sensitivity encoding (SENSE) algorithm for each spectral data point. Alternative methods for reconstruction with undersampled Cartesian k‐space data are the SMASH and GRAPPA algorithms that do the reconstruction in the k‐space domain. To reconstruct undersampled MRSI data with arbitrary k‐space trajectories, image‐domain‐based iterative SENSE algorithm has been applied at the cost of long computing times. In this paper, a new k‐space domain‐based parallel spectroscopic imaging reconstruction with arbitrary k‐space trajectories using k‐space sparse matrices is applied to MRSI with spiral k‐space trajectories. The algorithm achieves MRSI reconstruction with reduced memory requirements and computing times. The results are demonstrated in both phantom and in vivo studies. Spectroscopic images very similar to that reconstructed with fully sampled spiral k‐space data are obtained at different reduction factors. Magn Reson Med 61:267–272, 2009.
- 22 January 2009
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 61 (2) , 267-272
Open AccessParallel spectroscopic imaging reconstruction with arbitrary trajectories using k‐space sparse matrices
Parallel imaging reconstruction has been successfully applied to magnetic resonance spectroscopic imaging (MRSI) to reduce scan times. For undersampled k‐space data on a Cartesian grid, the reconstruction can be achieved in image domain using a sensitivity encoding (SENSE) algorithm for each spectral data point. Alternative methods for reconstruction with undersampled Cartesian k‐space data are the SMASH and GRAPPA algorithms that do the reconstruction in the k‐space domain. To reconstruct undersampled MRSI data with arbitrary k‐space trajectories, image‐domain‐based iterative SENSE algorithm has been applied at the cost of long computing times. In this paper, a new k‐space domain‐based parallel spectroscopic imaging reconstruction with arbitrary k‐space trajectories using k‐space sparse matrices is applied to MRSI with spiral k‐space trajectories. The algorithm achieves MRSI reconstruction with reduced memory requirements and computing times. The results are demonstrated in both phantom and in vivo studies. Spectroscopic images very similar to that reconstructed with fully sampled spiral k‐space data are obtained at different reduction factors. Magn Reson Med 61:267–272, 2009.
- Open Access
- 22 January 2009
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 61 (2) , 462-466
B1 and T1 insensitive water and lipid suppression using optimized multiple frequency-selective preparation pulses for whole-brain 1H spectroscopic imaging at 3T
- 22 January 2009
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 61 (2) , 462-466
Open AccessB1 and T1 insensitive water and lipid suppression using optimized multiple frequency-selective preparation pulses for whole-brain 1H spectroscopic imaging at 3T
- Open Access
- 25 August 2008
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 60 (3) , 542-547
Reproducibility study of whole‐brain 1H spectroscopic imaging with automated quantification
A reproducibility study of proton MR spectroscopic imaging (1H-MRSI) of the human brain was conducted to evaluate the reliability of an automated 3D in vivo spectroscopic imaging acquisition and associated quantification algorithm. A PRESS-based pulse sequence was implemented using dualband spectral-spatial RF pulses designed to fully excite the singlet resonances of choline (Cho), creatine (Cre), and N-acetyl aspartate (NAA) while simultaneously suppressing water and lipids; 1% of the water signal was left to be used as a reference signal for robust data processing, and additional lipid suppression was obtained using adiabatic inversion recovery. Spiral k-space trajectories were used for fast spectral and spatial encoding yielding high-quality spectra from 1 cc voxels throughout the brain with a 13-min acquisition time. Data were acquired with an 8-channel phased-array coil and optimal signal-to-noise ratio (SNR) for the combined signals was achieved using a weighting based on the residual water signal. Automated quantification of the spectrum of each voxel was performed using LCModel. The complete study consisted of eight healthy adult subjects to assess intersubject variations and two subjects scanned six times each to assess intrasubject variations. The results demonstrate that reproducible whole-brain 1H-MRSI data can be robustly obtained with the proposed methods. Magn Reson Med 60:542–547, 2008.
- 25 August 2008
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 60 (3) , 542-547
Open AccessReproducibility study of whole‐brain 1H spectroscopic imaging with automated quantification
A reproducibility study of proton MR spectroscopic imaging (1H-MRSI) of the human brain was conducted to evaluate the reliability of an automated 3D in vivo spectroscopic imaging acquisition and associated quantification algorithm. A PRESS-based pulse sequence was implemented using dualband spectral-spatial RF pulses designed to fully excite the singlet resonances of choline (Cho), creatine (Cre), and N-acetyl aspartate (NAA) while simultaneously suppressing water and lipids; 1% of the water signal was left to be used as a reference signal for robust data processing, and additional lipid suppression was obtained using adiabatic inversion recovery. Spiral k-space trajectories were used for fast spectral and spatial encoding yielding high-quality spectra from 1 cc voxels throughout the brain with a 13-min acquisition time. Data were acquired with an 8-channel phased-array coil and optimal signal-to-noise ratio (SNR) for the combined signals was achieved using a weighting based on the residual water signal. Automated quantification of the spectrum of each voxel was performed using LCModel. The complete study consisted of eight healthy adult subjects to assess intersubject variations and two subjects scanned six times each to assess intrasubject variations. The results demonstrate that reproducible whole-brain 1H-MRSI data can be robustly obtained with the proposed methods. Magn Reson Med 60:542–547, 2008.